1887

Abstract

Porcine epidemic diarrhea (PED) is a serious disease in piglets that leads to high mortality. An effective measure that provides higher IgA levels in the intestine and milk is required to decrease losses. Porcine epidemic diarrhea virus (PEDV) was dissolved in calcium alginate (Alg) and combined with chitosan (CS) via electrostatic interactions between cationic chitosan and anionic alginate to create a porous gel (Alg-CS+PEDV). The gel was used to immunize mice orally or in combination with subcutaneous injections of inactivated PEDV vaccine. At 12 and 24 days after immunization, levels of IgA and IgG in Alg-CS+PEDV were higher than with normal PEDV oral administration. At 24 days after immunization, the concentration of IFN-γ in Alg-CS+PEDV was higher than with normal PEDV oral administration. Furthermore, oral administration combining subcutaneous immunization induced higher levels of IgG and IgA than oral administration alone. Our study provides a new method for the preparation and administration of oral vaccines to achieve enhanced mucosal immunity against PEDV.

Funding
This study was supported by the:
  • National Natural Science Foundation of China (Award 31972658)
    • Principle Award Recipient: SongYunfeng
  • National Key Research and Development Program of China (Award 2021YFD1800303)
    • Principle Award Recipient: YunfengSong
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001979
2024-04-24
2024-05-04
Loading full text...

Full text loading...

References

  1. Li Y, Wu Q, Huang L, Yuan C, Wang J et al. An alternative pathway of enteric PEDV dissemination from nasal cavity to intestinal mucosa in swine. Nat Commun 2018; 9:3811 [View Article] [PubMed]
    [Google Scholar]
  2. Chattha KS, Roth JA, Saif LJ. Strategies for design and application of enteric viral vaccines. Annu Rev Anim Biosci 2015; 3:375–395 [View Article] [PubMed]
    [Google Scholar]
  3. Langel SN, Paim FC, Lager KM, Vlasova AN, Saif LJ. Lactogenic immunity and vaccines for porcine epidemic diarrhea virus (PEDV): historical and current concepts. Virus Res 2016; 226:93–107 [View Article] [PubMed]
    [Google Scholar]
  4. Roux ME, McWilliams M, Phillips-Quagliata JM, Weisz-Carrington P, Lamm ME. Origin of IgA-secreting plasma cells in the mammary gland. J Exp Med 1977; 146:1311–1322 [View Article] [PubMed]
    [Google Scholar]
  5. Saif LJ. Enteric viral infections of pigs and strategies for induction of mucosal immunity. Adv Vet Med 1999; 41:429–446 [View Article] [PubMed]
    [Google Scholar]
  6. Saif LJ, van Cott JL, Brim TA. Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine. Vet Immunol Immunopathol 1994; 43:89–97 [View Article] [PubMed]
    [Google Scholar]
  7. Wang D, Fang L, Xiao S. Porcine epidemic diarrhea in China. Virus Res 2016; 226:7–13 [View Article] [PubMed]
    [Google Scholar]
  8. Zhang E, Wang J, Li Y, Huang L, Wang Y et al. Comparison of oral and nasal immunization with inactivated porcine epidemic diarrhea virus on intestinal immunity in piglets. Exp Ther Med 2020; 20:1596–1606 [View Article] [PubMed]
    [Google Scholar]
  9. Yu M, Wang L, Ma S, Wang X, Wang Y et al. Immunogenicity of eGFP-marked recombinant Lactobacillus casei against transmissible gastroenteritis virus and porcine epidemic diarrhea virus. Viruses 2017; 9:274 [View Article] [PubMed]
    [Google Scholar]
  10. Poles J, Alvarez Y, Hioe CE. Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection. AIDS Res Hum Retroviruses 2014; 30:1027–1040 [View Article] [PubMed]
    [Google Scholar]
  11. Renukuntla J, Vadlapudi AD, Patel A, Boddu SHS, Mitra AK. Approaches for enhancing oral bioavailability of peptides and proteins. Int J Pharm 2013; 447:75–93 [View Article] [PubMed]
    [Google Scholar]
  12. Wang J, Huang L, Mou C, Zhang E, Wang Y et al. Mucosal immune responses induced by oral administration recombinant Bacillus subtilis expressing the COE antigen of PEDV in newborn piglets. Biosci Rep 2019; 39:BSR20182028 [View Article] [PubMed]
    [Google Scholar]
  13. Liu D, Ge J, Qiao X, Jiang Y, Liu S et al. High-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein. Appl Microbiol Biotechnol 2012; 93:2437–2446 [View Article] [PubMed]
    [Google Scholar]
  14. Huy NX, Kim YS, Jun SC, Jin Z, Park SM et al. Production of a heat-labile enterotoxin B subunit-porcine epidemic diarrhea virus-neutralizing epitope fusion protein in transgenic lettuce (Lactuca sativa). Biotechnol Bioprocess Eng 2009; 14:731–737 [View Article] [PubMed]
    [Google Scholar]
  15. Choe S, Song S, Piao D, Park GN, Shin J et al. Efficacy of orally administered porcine epidemic diarrhea vaccine-loaded hydroxypropyl methylcellulose phthalate microspheres and RANKL-secreting L. lactis. Vet Microbiol 2020; 242:108604 [View Article] [PubMed]
    [Google Scholar]
  16. Liang Y, He J, Guo B. Functional hydrogels as wound dressing to enhance wound healing. ACS Nano 2021; 15:12687–12722 [View Article] [PubMed]
    [Google Scholar]
  17. Huang J, Deng Y, Ren J, Chen G, Wang G et al. Novel in situ forming hydrogel based on xanthan and chitosan re-gelifying in liquids for local drug delivery. Carbohydr Polym 2018; 186:54–63 [View Article] [PubMed]
    [Google Scholar]
  18. Davitt CJ, McNeela EA, Longet S, Tobias J, Aversa V et al. A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens. J Control Release 2016; 233:162–173 [View Article] [PubMed]
    [Google Scholar]
  19. Huang L, Wang J, Wang Y, Zhang E, Li Y et al. Upregulation of CD4(+)CD8(+) memory cells in the piglet intestine following oral administration of Bacillus subtilis spores combined with PEDV whole inactivated virus. Vet Microbiol 2019; 235:1–9 [View Article] [PubMed]
    [Google Scholar]
  20. Lee Y, Kamada N, Moon JJ. Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome. Adv Drug Deliv Rev 2021; 179:114021 [View Article] [PubMed]
    [Google Scholar]
  21. Jung K, Eyerly B, Annamalai T, Lu Z, Saif LJ. Structural alteration of tight and adherens junctions in villous and crypt epithelium of the small and large intestine of conventional nursing piglets infected with porcine epidemic diarrhea virus. Vet Microbiol 2015; 177:373–378 [View Article] [PubMed]
    [Google Scholar]
  22. Jung K, Wang Q, Scheuer KA, Lu Z, Zhang Y et al. Pathology of US porcine epidemic diarrhea virus strain PC21A in gnotobiotic pigs. Emerg Infect Dis 2014; 20:662–665 [View Article] [PubMed]
    [Google Scholar]
  23. Crawford K, Lager KM, Kulshreshtha V, Miller LC, Faaberg KS. Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada. Virus Res 2016; 226:108–116 [View Article] [PubMed]
    [Google Scholar]
  24. Lee C. Porcine epidemic diarrhea virus: an emerging and re-emerging epizootic swine virus. Virol J 2015; 12:193 [View Article] [PubMed]
    [Google Scholar]
  25. Cirri M, Maestrelli F, Scuota S, Bazzucchi V, Mura P. Development and microbiological evaluation of chitosan and chitosan-alginate microspheres for vaginal administration of metronidazole. Int J Pharm 2021; 598:120375 [View Article] [PubMed]
    [Google Scholar]
  26. Sorasitthiyanukarn FN, Muangnoi C, Rojsitthisak P, Rojsitthisak P. Chitosan-alginate nanoparticles as effective oral carriers to improve the stability, bioavailability, and cytotoxicity of curcumin diethyl disuccinate. Carbohydr Polym 2021; 256:117426 [View Article] [PubMed]
    [Google Scholar]
  27. Straccia MC, d’Ayala GG, Romano I, Oliva A, Laurienzo P. Alginate hydrogels coated with chitosan for wound dressing. Mar Drugs 2015; 13:2890–2908 [View Article] [PubMed]
    [Google Scholar]
  28. Jafari B, Rafie F, Davaran S. Preparation and characterization of a novel smart polymeric hydrogel for drug delivery of insulin. Bioimpacts 2011; 1:135–143 [View Article] [PubMed]
    [Google Scholar]
  29. Jose S, Fangueiro JF, Smitha J, Cinu TA, Chacko AJ et al. Cross-linked chitosan microspheres for oral delivery of insulin: taguchi design and in vivo testing. Colloids Surf B Biointerfaces 2012; 92:175–179 [View Article] [PubMed]
    [Google Scholar]
  30. Ling K, Wu H, Neish AS, Champion JA. Alginate/chitosan microparticles for gastric passage and intestinal release of therapeutic protein nanoparticles. J Control Release 2019; 295:174–186 [View Article] [PubMed]
    [Google Scholar]
  31. Wang Y, Hu R, Guo Y, Qin W, Zhang X et al. Preparation, evaluation, and in vitro release of chitosan-alginate tanshinone self-microemulsifying sustained-release microcapsules. Technol Health Care 2021; 29:687–695 [View Article] [PubMed]
    [Google Scholar]
  32. Ho DK, Frisch S, Biehl A, Terriac E, De Rossi C et al. Farnesylated glycol chitosan as a platform for drug delivery: synthesis, characterization, and investigation of mucus-particle interactions. Biomacromolecules 2018; 19:3489–3501 [View Article] [PubMed]
    [Google Scholar]
  33. Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010; 10:787–796 [View Article] [PubMed]
    [Google Scholar]
  34. Newsted D, Fallahi F, Golshani A, Azizi A. Advances and challenges in mucosal adjuvant technology. Vaccine 2015; 33:2399–2405 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001979
Loading
/content/journal/jgv/10.1099/jgv.0.001979
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error